Smith Nephew Company Leadership
SNN Stock | USD 23.84 0.17 0.71% |
Smith Nephew employs about 18.5 K people. The company is managed by 58 executives with a total tenure of roughly 377 years, averaging almost 6.0 years of service per executive, having 318.14 employees per reported executive. Analysis of Smith Nephew's management performance can provide insight into the firm performance.
Roland Diggelmann CEO Chief Executive Officer, Executive Director |
Namal Nawana CEO Chief Executive Officer, Executive Director |
Smith |
Smith Nephew's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Smith Nephew's future performance. Based on our forecasts, it is anticipated that Smith will maintain a workforce of about 18450 employees by May 2024.Smith Nephew's latest congressional trading
Congressional trading in companies like Smith Nephew SNATS, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Smith Nephew by those in governmental positions are based on the same information available to the general public.
2023-07-10 | Representative Daniel Goldman | Disposed $15K to $50K | Verify | ||
2021-02-26 | Representative Michael T. McCaul | Acquired $15K to $50K | Verify |
Smith Nephew Management Team Effectiveness
The company has Return on Asset of 0.0427 % which means that on every $100 spent on assets, it made $0.0427 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0502 %, implying that it generated $0.0502 on every 100 dollars invested. Smith Nephew's management efficiency ratios could be used to measure how well Smith Nephew manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of April 2024, Return On Tangible Assets is likely to drop to 0.04. In addition to that, Return On Capital Employed is likely to drop to 0.12. At this time, Smith Nephew's Total Assets are very stable compared to the past year. As of the 19th of April 2024, Non Current Assets Total is likely to grow to about 6.3 B, while Other Current Assets are likely to drop about 87.4 M.As of the 19th of April 2024, Common Stock Shares Outstanding is likely to grow to about 551.8 M. Also, Net Income Applicable To Common Shares is likely to grow to about 499 M
Smith Nephew Workforce Comparison
Smith Nephew SNATS is rated third in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 226,310. Smith Nephew holds roughly 18,452 in number of employees claiming about 8% of equities under Health Care industry.
Smith Nephew Profit Margins
The company has Net Profit Margin of 0.05 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.14 %, which entails that for every 100 dollars of revenue, it generated $0.14 of operating income.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.58 | 0.667 |
|
| |||||
Net Profit Margin | 0.045 | 0.0474 |
|
| |||||
Operating Profit Margin | 0.19 | 0.1689 |
|
| |||||
Pretax Profit Margin | 0.0548 | 0.0577 |
|
| |||||
Return On Assets | 0.025 | 0.0263 |
|
| |||||
Return On Equity | 0.0479 | 0.0504 |
|
|
Smith Nephew SNATS Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Smith Nephew SNATS Price Series Summation is a cross summation of Smith Nephew price series and its benchmark/peer.
Smith Nephew Notable Stakeholders
A Smith Nephew stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Smith Nephew often face trade-offs trying to please all of them. Smith Nephew's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Smith Nephew's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Roland Diggelmann | Chief Executive Officer, Executive Director | Profile | |
Namal Nawana | Chief Executive Officer, Executive Director | Profile | |
Deepak Nath | Chief Executive Officer | Profile | |
Olivier Bohuon | CEO, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination and Governance Committee | Profile | |
Roberto Quarta | Non-Executive Independent Chairman of the Board | Profile | |
Simon Fraser | President - Advanced Wound Management and Global Commercial Operations | Profile | |
Massimiliano Colella | President Europe - Middle East and Africa | Profile | |
Glenn Warner | President - Advanced Wound Management | Profile | |
Paul Connolly | President Operations | Profile | |
Phil Cowdy | Executive Vice President of Business Development & Corporate Affairs | Profile | |
Mark Gladwell | President - Global Operations and Global Business Services | Profile | |
Vasant Padmanabhan | President - Research & Development | Profile | |
Diogo MoreiraRato | President - Europe and Canada | Profile | |
Skip Kiil | President - Orthopedics | Profile | |
Matthew Stober | President - Global Operations | Profile | |
Rodrigo Bianchi | Interim President - Asia Pacific | Profile | |
Bradley Cannon | President Orthopaedics | Profile | |
Michael Frazzette | President - Advanced Surgical Devices | Profile | |
Gordon Howe | President of Global Operations | Profile | |
Brad Cannon | President - Sports Medicine & ENT | Profile | |
Ian Melling | Interim Chief Financial Officer | Profile | |
Michael Friedman | Non-Executive Independent Director | Profile | |
Vinita Bali | Non-Executive Independent Director | Profile | |
John Rogers | CFO Director | Profile | |
Graham Baker | Chief Financial Officer, Executive Director | Profile | |
Rick Medlock | Non-Executive Independent Director | Profile | |
Angie Risley | Non-Executive Independent Director | Profile | |
John Ma | Non-Executive Independent Director | Profile | |
Joseph Papa | Non-Executive Independent Director | Profile | |
Ian Barlow | Non-Executive Independent Director | Profile | |
Bob White | Non-Executive Independent Director | Profile | |
Erik Engstrom | Non-Executive Independent Director | Profile | |
Marc Owen | Non-Executive Independent Director | Profile | |
AnneFrancoise Nesmes | Chief Financial Officer, Executive Director | Profile | |
Brian Larcombe | Senior Independent Non-Executive Director | Profile | |
Katarzyna MazurHofsaess | Non-Executive Independent Director | Profile | |
Julie Brown | CFO, Director and Member of Disclosures Committee | Profile | |
Robin Freestone | Senior Non-Executive Independent Director | Profile | |
Virginia Bottomley | Non-Executive Independent Director | Profile | |
Ingeborg Oie | VP, Investor Relations | Profile | |
Helen Barraclough | Company Counsel | Profile | |
Gunthorp Oie | IR Contact Officer | Profile | |
Helen Maye | Chief Human Resources Officer | Profile | |
Cathy ORourke | Chief Legal and Compliance Officer | Profile | |
Joe Metzger | Senior Communications | Profile | |
Susan Swabey | Company Secretary | Profile | |
Melissa Guerdan | Chief Quality and Regulatory Affairs Officer | Profile | |
Philip Cowdy | Chief Officer | Profile | |
Alison Parkes | Chief Officer | Profile | |
Elga Lohler | Chief Human Resource Officer | Profile | |
Cyrille Petit | Chief Corporate Development Officer | Profile | |
Peter Coenen | President - EMEA Region | Profile | |
Myra Eskes | President - Asia Pacific | Profile | |
Andrew Swift | Vice Relations | Profile | |
Steve Kane | Global US | Profile | |
John Campo | Chief Legal Officer | Profile | |
Jo Hallas | Non-Executive Director | Profile | |
Catheryn ORourke | Chief Legal and Compliance Officer | Profile |
About Smith Nephew Management Performance
The success or failure of an entity such as Smith Nephew SNATS often depends on how effective the management is. Smith Nephew management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Smith management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Smith management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.04 | 0.04 | |
Return On Capital Employed | 0.12 | 0.12 | |
Return On Assets | 0.03 | 0.03 | |
Return On Equity | 0.05 | 0.05 |
The data published in Smith Nephew's official financial statements usually reflect Smith Nephew's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Smith Nephew SNATS. For example, before you start analyzing numbers published by Smith accountants, it's critical to develop an understanding of what Smith Nephew's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Smith Nephew's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Smith Nephew's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Smith Nephew's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Smith Nephew SNATS. Please utilize our Beneish M Score to check the likelihood of Smith Nephew's management manipulating its earnings.
Smith Nephew Workforce Analysis
Traditionally, organizations such as Smith Nephew use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Smith Nephew within its industry.Smith Nephew Manpower Efficiency
Return on Smith Nephew Manpower
Revenue Per Employee | 300.7K | |
Revenue Per Executive | 95.7M | |
Net Income Per Employee | 14.3K | |
Net Income Per Executive | 4.5M | |
Working Capital Per Employee | 95.3K | |
Working Capital Per Executive | 30.3M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Smith Nephew SNATS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Smith Stock analysis
When running Smith Nephew's price analysis, check to measure Smith Nephew's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Smith Nephew is operating at the current time. Most of Smith Nephew's value examination focuses on studying past and present price action to predict the probability of Smith Nephew's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Smith Nephew's price. Additionally, you may evaluate how the addition of Smith Nephew to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Transaction History View history of all your transactions and understand their impact on performance |
Is Smith Nephew's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Smith Nephew. If investors know Smith will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Smith Nephew listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.983 | Dividend Share 0.375 | Earnings Share 0.6 | Revenue Per Share 2.5484 | Quarterly Revenue Growth 0.076 |
The market value of Smith Nephew SNATS is measured differently than its book value, which is the value of Smith that is recorded on the company's balance sheet. Investors also form their own opinion of Smith Nephew's value that differs from its market value or its book value, called intrinsic value, which is Smith Nephew's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Smith Nephew's market value can be influenced by many factors that don't directly affect Smith Nephew's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Smith Nephew's value and its price as these two are different measures arrived at by different means. Investors typically determine if Smith Nephew is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Smith Nephew's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.